Latest Breaking News On - Dose escalation - Page 6 : comparemela.com

Kura Oncology, Inc (NASDAQ:KURA) Q3 2023 Earnings Call Transcript

Kura Oncology, Inc. (NASDAQ:KURA) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Good afternoon, ladies and gentlemen, and welcome to the Third Quarter 2023 Kura Oncology Inc. Earnings Conference Call. At this time, all lines are in listen-only mode. Following the presentation, we will conduct a question-and-answer session. [Operator Instructions] This call is being […]

Troy wilsonTom doyleEuropean society for medical oncology congressEuropean societyMedical oncology congressMirati therapeuticsBiggest housing shortageTrafficking citiesClinical dataPete de spainTom doyleStandards of careDose escalation

Form 425 First Light Acquisition Filed by: First Light Acquisition Group, Inc

Form 425 First Light Acquisition Filed by: First Light Acquisition Group, Inc
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesSan diegoCalidi allogeneicAllan camaisaSantosh kesariStephen thesingPancrepaasncreas capanAntoniof santidrianBoris minevThomas vecchiollaDmitriy zamarinNeuronova boris minevTony kalajianMichaelj alberAshok srivastavaHeehyoung lee

Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD

Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD
charlotteobserver.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from charlotteobserver.com Daily Mail and Mail on Sunday newspapers.

United statesAlec baldwinKevin harringtonJulian bailesPsycheceutical neurodirectLife sciencesDrug development deliveryPty ltdPsycheceutical bioscience incSafety review committeeDose escalationPhasei trialNeurodirect ketaminePost traumatic stress disorderChad harmanPharmacy times

Elucida Oncology Announces First Patient Dosed with ELU001 in Expansion Cohort of its Phase 1/2 Clinical Trial

Elucida Oncology Announces First Patient Dosed with ELU001 in Expansion Cohort of its Phase 1/2 Clinical Trial
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesGeno germanoPaul rudickElucida oncology incTumor group expansion cohortsAmerican association for cancer researchOncology announces first patient dosedExpansion cohortExpansion cohortsDose escalationAmerican associationCancer researchElucida oncology

Elucida Oncology Announces First Patient Dosed with ELU001 in Expansion Cohort of its Phase 1/2

MONMOUTH JUNCTION, N.J., July 20, 2023 (GLOBE NEWSWIRE) Elucida Oncology, a clinical-stage biotechnology company developing the next frontier in targeted cancer therapy, announced today that the first patient has

United statesPaul rudickGeno germanoAmerican association for cancer researchTumor group expansion cohortsElucida oncology incExpansion cohortsDose escalationAmerican associationCancer researchElucida oncology